Prostate, Fenugreek Case
Study
BACK
to questions
Prostate Cancer Program, Sidney Kimmel Comprehensive Cancer Center at Johns
Hopkins University, Baltimore, Maryland, USA.
"In
recent years, various dietary components that can potentially be used for the
prevention and treatment of cancer have been identified. In this study, we
demonstrate that extract (FE) from the seeds of the plant Trigonella foenum
graecum, commonly called fenugreek, are cytotoxic in vitro to a panel of cancer
but not normal cells. Treatment with 10-15 ug/mL of FE for 72 h was growth
inhibitory to breast, pancreatic and prostate cancer cell lines (PCa). When
tested at higher doses (15-20 ug/mL), FE continued to be growth inhibitory to
PCa cell lines but not to either primary prostate or hTert-immortalized prostate
cells. At least part of the growth inhibition is due to induction of cell death,
as seen by incorporation of Ethidium Bromide III into cancer cells exposed to
FE. Molecular changes induced in PCa cells are: in DU-145 cells: downregulation
of mutant p53, and in PC-3 cells upregulation of p21 and inhibition of TGFbeta
induced phosphorylation of Akt. The surprising finding of our studies is that
death of cancer cells occurs despite growth stimulatory pathways being
simultaneously upregulated (phosphorylated) by FE. Thus, these studies add
another biologically active agent to our armamentarium of naturally occurring
agents with therapeutic potential".